Clinical Trial

Sarcopenia Among Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
\- Determination of sarcopenia frequency among patients with metabolic dysfunction-associated steatotic liver disease 2- Exploring the association of sarcopenia with disease state (steatosis grade and fibrosis) among patients with metabolic dysfunction-associated steatotic liver disease
Trial Details
NCT Number NCT07598916
Lead Sponsor Assiut University
Conditions Sarcopenia Among Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
Enrollment 120 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-20